Eris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

1,486.71

1,330.73

1,215.73

1,108.83

1,020.23

Operating profit

453.81

505.11

484.00

417.31

355.49

Interest

57.42

20.81

2.99

0.78

1.85

Gross profit

431.22

501.57

509.99

426.53

368.36

EPS (Rs)

22.03

29.27

30.69

25.82

21.41

Other income

34.83

17.26

28.99

10.00

14.73

Stock adjustment

-13.15

8.50

2.49

-12.57

17.47

Raw material

96.29

114.13

117.57

99.43

76.88

Power and fuel

-

-

-

-

-

Employee expenses

331.67

252.52

222.18

207.02

191.39

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

618.08

450.46

389.49

397.65

379.01

Provisions made

-

-

-

-

-

Depreciation

102.39

64.66

51.46

37.64

44.90

Taxation

29.12

38.90

41.35

38.29

32.71

Net profit / loss

299.71

398.01

417.19

350.61

290.75

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.60

13.60

13.59

13.58

13.58

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

30.52

37.96

39.81

37.64

34.84

GPM (%)

28.34

37.21

40.97

38.12

35.59

NPM (%)

19.70

29.53

33.52

31.34

28.09